Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Telix Pharmaceuticals Logo
Telix Pharmaceuticals Growth Score
83
CB Rank
8445
Heat Score
83
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Founded
obfuscation
PublicPost-IPO Debt Melbourne, Victoria, Australia251-500 www.telixpharma.com
Biotechnology
Overview

Telix Pharmaceuticals
Total Funding
obfuscation
Growth Score
83
Heat Score
83

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score83
0 pts
in past quarter
Heat Score 83
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+3 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Telix Pharmaceuticals

CB Rank
8445
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Founded
obfuscation
PublicPost-IPO Debt Melbourne, Victoria, Australia251-500 www.telixpharma.com
Biotechnology

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Helen Hovenga
    Helen Hovenga: Chief People Officer
  • Photo of Melanie Farris
    Melanie Farris: SVP Global Governance, Risk and Compliance
    Past Role: Telix Pharmaceuticals, Chief Governance and Risk Officer, Group Company Secretary

Details

Legal Name Telix Pharmaceuticals Ltd
Operating Status Active
Number of Exits 
obfuscation
Stock Symbol  ASX:TLX
Company Type For Profit
Founders  Christian Behrenbruch
About the Company
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Contact Email info@telixpharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Telix Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Illuccix
A prostate cancer imaging agent using PSMA PET/CT technology for staging high-risk patients, identifying suspected recurrence, and selecting for PSMA-directed lutetium therapy.
TLX250-CDx
A diagnostic agent targeting CAIX for non-invasive detection of clear cell renal cell carcinoma, providing high accuracy in identifying the clear cell phenotype.

Research & Development

Telix Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Telix Pharmaceuticals Logo
Post-IPO Debt - Telix Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Australian Government Logo
Australian Government
Yes
Grant - Telix Pharmaceuticals Logo
Grant - Telix Pharmaceuticals
—
Australian Government Logo
Australian Government
Yes
Grant - Telix Pharmaceuticals Logo
Grant - Telix Pharmaceuticals
—
Australian Government Logo
Australian Government
Yes
Grant - Telix Pharmaceuticals Logo
Grant - Telix Pharmaceuticals
—
Australian Government Logo
Australian Government
Yes
Grant - Telix Pharmaceuticals Logo
Grant - Telix Pharmaceuticals
—
Australian Government Logo
Australian Government
Yes
Grant - Telix Pharmaceuticals Logo
Grant - Telix Pharmaceuticals
—

Investments

Number of Investments 1
Number of Exits 
obfuscation
Number of Acquisitions 11
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation

Investment Breakdown

Number of Investments 1
Number of Exits 
obfuscation
Number of Acquisitions 11
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
obfuscation
Mauna Kea Technologies Logo
Mauna Kea Technologies
Yes
Post-IPO Equity - Mauna Kea Technologies Logo
Post-IPO Equity - Mauna Kea Technologies
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 8 Board Members and Advisors 3 Contacts 283

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

21,165
12.96%
 in past month

Interest Signals

TopicSurge Score
Device Security Logo
Device Security
100
Payroll Logo
Payroll
100
Software as a Service (SaaS) Analytics Logo
Software as a Service (SaaS) Analytics
100

Actively Used Products

21Telix Pharmaceuticals uses 21 technology products and services including HTML5, Google Tag Manager, and  Microsoft Outlook, according to G2 Stack.

Active Website Tech Count

23Telix Pharmaceuticals is actively using 23 technologies for its website, according to BuiltWith. These include DNSSEC, U.S. Server Location, and  Amazon.

Total IP

65Telix Pharmaceuticals has registered 65 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
ImaginAb Logo
ImaginAbSubsidiary
Frequently Asked Questions

Where is Telix Pharmaceuticals's headquarters? Telix Pharmaceuticals is located in Melbourne, Victoria, Australia.Who invested in Telix Pharmaceuticals? Telix Pharmaceuticals is funded by Australian Government.When was the last funding round for Telix Pharmaceuticals? Telix Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Telix Pharmaceuticals's competitors? Alternatives and possible competitors to Telix Pharmaceuticals may include Parabilis Medicines, ARTBIO, and  Ferronova.How much funding has Telix Pharmaceuticals raised to date? Telix Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|